These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29019697)

  • 21. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
    Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
    Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical probes for protein arginine methyltransferases.
    Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
    Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
    Zhang WY; Lu WC; Jiang H; Lv ZB; Xie YQ; Lian FL; Liang ZJ; Jiang YX; Wang DJ; Luo C; Jin J; Ye F
    Chem Biol Drug Des; 2017 Dec; 90(6):1260-1270. PubMed ID: 28636189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases.
    Li X; Zhang L; Xu J; Liu C; Zhang X; Abdelmoneim AA; Zhang Q; Ke J; Zhang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Chem Inf Model; 2022 Feb; 62(3):692-702. PubMed ID: 35098713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).
    Therrien E; Larouche G; Manku S; Allan M; Nguyen N; Styhler S; Robert MF; Goulet AC; Besterman JM; Nguyen H; Wahhab A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6725-32. PubMed ID: 19836951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.
    Osborne T; Roska RL; Rajski SR; Thompson PR
    J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.
    Wang J; Chen L; Sinha SH; Liang Z; Chai H; Muniyan S; Chou YW; Yang C; Yan L; Feng Y; Li KK; Lin MF; Jiang H; Zheng YG; Luo C
    J Med Chem; 2012 Sep; 55(18):7978-87. PubMed ID: 22928876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity-based protein profiling of protein arginine methyltransferase 1.
    Obianyo O; Causey CP; Jones JE; Thompson PR
    ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.
    Liu Z; Lin M; Liu C; Chen X; Chen Q; Li X; Wu X; Wang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Med Chem; 2024 Apr; 67(8):6313-6326. PubMed ID: 38574345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay.
    Song Y; Li L; Chen Y; Liu J; Xiao S; Lian F; Zhang N; Ding H; Zhang Y; Chen K; Jiang H; Zhang C; Liu YC; Chen S; Luo C
    Bioorg Med Chem; 2018 May; 26(8):1751-1758. PubMed ID: 29534934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
    Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
    Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
    Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
    ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
    Gao Y; Feng C; Ma J; Yan Q
    Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation.
    Shin DY; Park YS; Yang K; Kim GY; Kim WJ; Han MH; Kang HS; Choi YH
    Int J Oncol; 2012 Sep; 41(3):910-8. PubMed ID: 22767021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia.
    Guo Z; Zhang Z; Yang H; Cao D; Xu X; Zheng X; Chen D; Wang Q; Li Y; Li J; Du Z; Wang X; Chen L; Ding J; Shen J; Geng M; Huang X; Xiong B
    J Med Chem; 2019 Jun; 62(11):5414-5433. PubMed ID: 31117515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).
    Morales Y; Cáceres T; May K; Hevel JM
    Arch Biochem Biophys; 2016 Jan; 590():138-152. PubMed ID: 26612103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
    Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
    Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory study of protein arginine methyltransferase 1 using a fluorescent approach.
    Feng Y; Xie N; Wu J; Yang C; Zheng YG
    Biochem Biophys Res Commun; 2009 Feb; 379(2):567-72. PubMed ID: 19121292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).
    Obianyo O; Thompson PR
    J Biol Chem; 2012 Feb; 287(8):6062-71. PubMed ID: 22219200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.
    Fong JY; Pignata L; Goy PA; Kawabata KC; Lee SC; Koh CM; Musiani D; Massignani E; Kotini AG; Penson A; Wun CM; Shen Y; Schwarz M; Low DH; Rialdi A; Ki M; Wollmann H; Mzoughi S; Gay F; Thompson C; Hart T; Barbash O; Luciani GM; Szewczyk MM; Wouters BJ; Delwel R; Papapetrou EP; Barsyte-Lovejoy D; Arrowsmith CH; Minden MD; Jin J; Melnick A; Bonaldi T; Abdel-Wahab O; Guccione E
    Cancer Cell; 2019 Aug; 36(2):194-209.e9. PubMed ID: 31408619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.